Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2001

View Archived Issues

Researchers reveal crystal structure of antibody against HIV

Testosterone protects human primary neurons from apoptosis

Hormone replacement therapy has osteoprotective effects in elderly women

Ultracet combination analgesic approved by FDA for acute pain relief

Seattle Genetics initiates phase II trial with SGN-15

Chrysalis reports positive trends from pilot Chrysalin clinical trial for diabetic ulcers

Immunex and Wyeth-Ayerst to commence longitudinal rheumatoid arthritis study

Novogen to initiate clinical trial of oral phenoxodiol in advanced prostate cancer

Ivax announces encouraging phase I results of BNP-166 as treatment of Crohn's disease

Biomira and Merck KGaA to meet with FDA regarding Theratope vaccine

Visudyne approved for additional ocular conditions in the U.S.

Enrollment for study of Zadaxin in hepatitis B in Japan completed

Lilly and Isis establish antisense strategic alliance

Study of Cytran's IM-862 in ovarian cancer begins at Magee-Womens Hospital

Revised Remicade label strengthens warnings about risk of infections

Schering-Plough highlights next-generation farnesyl protein transferase inhibitors at ACS meeting

Patient dosing completed in phase II study of Alista for treatment of FSD

Selective beta3-adrenoceptor agonists designed at Asahi Kasei

Sterix patents novel steroid sulfatase inhibitors

Potent inhibitors of IL-5 gene expression identified at Abbott

Jenapharm reports compounds with affinity for progesterone and/or glucocorticoid receptors

New series of inhibitors of TNF production may be useful as immunosuppressants

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...